OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $103,415 | -23.5% | 30,870 | -1.0% | 0.00% | – |
Q2 2023 | $135,265 | +12.5% | 31,167 | -2.8% | 0.00% | – |
Q1 2023 | $120,263 | +52.9% | 32,070 | +43.9% | 0.00% | – |
Q4 2022 | $78,652 | +74.8% | 22,281 | 0.0% | 0.00% | – |
Q3 2022 | $45,000 | +4.7% | 22,281 | 0.0% | 0.00% | – |
Q2 2022 | $43,000 | -35.8% | 22,281 | +7.4% | 0.00% | – |
Q1 2022 | $67,000 | -13.0% | 20,746 | +0.7% | 0.00% | – |
Q4 2021 | $77,000 | +24.2% | 20,596 | +69.8% | 0.00% | – |
Q3 2021 | $62,000 | – | 12,131 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |